EPISODE · Jun 8, 2021 · 20 MIN
Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
from Keeping Current CME
Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection. Credit available for this activity expires: 6/7/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952387?src=mkm_podcast_addon_952387
Embed this episode
NOW PLAYING
Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
0:00
20:01
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 20 minutes long.
When was this Keeping Current CME episode published?
This episode was published on June 8, 2021.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!